CD2 (T-cell surface antigen CD2) variants and mutations
CD2 (also known as T-cell surface antigen CD2) is a human protein-coding gene encoding a t-cell surface antigen protein. It strengthens adhesion and signaling between T cells or natural-killer cells and antigen-presenting target cells through interactions including CD58. Altered expression affects lymphocyte activation and is also used diagnostically and therapeutically in selected hematologic diseases. This analysis covers 685 CD2 variants and mutations. Of these, 96% have computational variant effect predictions. Disease context includes hypothyroidism, rheumatoid arthritis, and Graves disease. Example CD2 variants include S2R, S2S, and F3C.
Variant analysis overview
- Gene: CD2
- Protein: T-cell surface antigen CD2
- UniProt accession: P06729
- Organism: Homo sapiens
- Variants analyzed: 685
- Variant scope: all variants
- Completed: 2026-08-20
Variant and mutation evidence
- Variant composition: 426 unspecified-consequence records; 109 synonymous variants; 120 missense variants; 13 frameshift variants; 3 splice-region variants; 10 stop-gained variants; 3 stop lost; 1 stop retained variant
- Prediction scores: 655 variants have prediction scores (96% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: hypothyroidism, rheumatoid arthritis, Graves disease, myxedema, psoriasis vulgaris, immune system disorder, Pain, thyroid gland disorder, kidney disorder, psoriasis, ankylosing spondylitis, neutropenia.
Protein structure and variant hotspots
- Protein features: 1 transmembrane segments; 2 domains; 3 post-translational modification sites.
- Structural context: 454 variants have structural context.
- PTM context: 4 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable CD2 variants
Examples include S2R, S2S, F3C, F3S, P4L, P4P, C5Y, C5L. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- S2R (p.Ser2Arg), ExAC rs753429490, TOPMed rs753429490, gnomAD rs753429490, REVEL 0.15, MetaLR 0.12
- S2S (p.Ser2Ser), gnomAD 1-116754498-C-T, CADD 1.88
- F3C (p.Phe3Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- F3S (p.Phe3Ser), gnomAD 1-116754500-T-C, REVEL 0.20, MetaLR 0.18
- P4L (p.Pro4Leu), cosmic curated COSV10468, ExAC rs759143872, gnomAD rs759143872, MetaLR 0.20, MetaSVM -0.89
- P4P (p.Pro4Pro), rs764596367, gnomAD 1-116754504-A-G, CADD 2.21
- C5Y (p.Cys5Tyr), TOPMed rs989279218, REVEL 0.16, MetaLR 0.21
- C5L (p.Cys5Leu), gnomAD 1-116754505-TG-T, CADD 16.80
- C5F (p.Cys5Phe), gnomAD 1-116754506-G-T, REVEL 0.33, MetaLR 0.39
- C5C (p.Cys5Cys), rs200876575, gnomAD 1-116754507-T-C, CADD 5.94
- K6E (p.Lys6Glu), TOPMed rs1469572192, gnomAD rs1469572192, REVEL 0.12, MetaLR 0.14, Uncertain significance, not specified
- V8L (p.Val8Leu), TOPMed rs1651769569, gnomAD rs1651769569, REVEL 0.14, MetaLR 0.05
- V8I (p.Val8Ile), gnomAD 1-116754514-G-A, REVEL 0.11, MetaLR 0.14
- A9D (p.Ala9Asp), ExAC rs757654518, gnomAD rs757654518
- A9G (p.Ala9Gly), ExAC rs757654518, gnomAD rs757654518
- A9S (p.Ala9Ser), Ensembl rs1651769647, REVEL 0.26, MetaLR 0.39
- A9T (p.Ala9Thr), Ensembl rs1651769647, MetaLR 0.40, MetaSVM -0.64
- S10I (p.Ser10Ile), TOPMed rs906824892, gnomAD rs906824892, REVEL 0.54, MetaLR 0.52
- S10R (p.Ser10Arg), TOPMed rs1651770060, MetaLR 0.42, MetaSVM -0.56
- S10N (p.Ser10Asn), gnomAD 1-116754521-G-A, REVEL 0.31, MetaLR 0.51
- S10S (p.Ser10Ser), gnomAD 1-116754522-C-T, CADD 7.60
- L12R (p.Leu12Arg), gnomAD 1-116754527-T-G, REVEL 0.60, MetaLR 0.55
- L13P (p.Leu13Pro), cosmic curated COSV10592, Ensembl rs113170334, MetaLR 0.60, MetaSVM 0.29
- L13L (p.Leu13Leu), rs1651770186, gnomAD 1-116754529-C-T, CADD 7.29
- L13R (p.Leu13Arg), gnomAD 1-116754530-T-G, REVEL 0.67, MetaLR 0.59
- I14V (p.Ile14Val), gnomAD rs1362083973, REVEL 0.28, MetaLR 0.28
- I14M (p.Ile14Met), gnomAD 1-116754534-T-G, REVEL 0.31, MetaLR 0.41
- F15L (p.Phe15Leu), gnomAD 1-116754537-C-G, REVEL 0.33, MetaLR 0.41
- F15F (p.Phe15Phe), rs1651770713, gnomAD 1-116754537-C-T, CADD 9.08
- N16D (p.Asn16Asp), ExAC rs780477399, TOPMed rs780477399, gnomAD rs780477399, REVEL 0.19, MetaLR 0.10
- N16H (p.Asn16His), ExAC rs780477399, TOPMed rs780477399, gnomAD rs780477399, REVEL 0.25, MetaLR 0.14
- N16S (p.Asn16Ser), ExAC rs749408773, gnomAD rs749408773, REVEL 0.15, MetaLR 0.07
- V17I (p.Val17Ile), gnomAD rs201028316, REVEL 0.08, MetaLR 0.16
- S18S (p.Ser18Ser), rs768781886, gnomAD 1-116754546-T-C, CADD 3.92
- S19F (p.Ser19Phe), NCI-TCGA Cosmic COSV6564, cosmic curated COSV65643, Variant assessed as somatic; moderate impact.
- S19P (p.Ser19Pro), ExAC rs778816590, TOPMed rs778816590, gnomAD rs778816590, REVEL 0.30, MetaLR 0.24
- K20E (p.Lys20Glu), TOPMed rs1349995035, gnomAD rs1349995035, REVEL 0.28, MetaLR 0.42
- K20R (p.Lys20Arg), TOPMed rs1651771652, gnomAD rs1651771652, REVEL 0.22, MetaLR 0.44
- K20Q (p.Lys20Gln), gnomAD 1-116754550-A-C, REVEL 0.25, MetaLR 0.33
- G21D (p.Gly21Asp), TOPMed rs1651775957
- G21V (p.Gly21Val), TOPMed rs1651775957
- G21G (p.Gly21Gly), rs1233905282, gnomAD 1-116754632-T-G, CADD 8.28
- A22A (p.Ala22Ala), gnomAD 1-116754635-A-G, CADD 0.17
- V23F (p.Val23Phe), NCI-TCGA Cosmic COSV6564, cosmic curated COSV65643, MetaLR 0.25, MetaSVM -0.80, Variant assessed as somatic; moderate impact.
- V23D (p.Val23Asp), gnomAD 1-116754637-T-A, REVEL 0.14, MetaLR 0.13
- V23V (p.Val23Val), rs746891120, gnomAD 1-116754638-C-A, CADD 1.27
- S24A (p.Ser24Ala), ExAC rs776251862, TOPMed rs776251862, gnomAD rs776251862, REVEL 0.16, MetaLR 0.07
- K25E (p.Lys25Glu), Ensembl rs2101152211, REVEL 0.13, MetaLR 0.10
- K25R (p.Lys25Arg), rs1201404636, ClinGen CA341839397, ClinVar RCV004363726, gnomAD rs1201404636, REVEL 0.08, MetaLR 0.09, Uncertain significance, not specified
- K25Q (p.Lys25Gln), gnomAD 1-116754642-A-C, REVEL 0.16, MetaLR 0.09
- K25K (p.Lys25Lys), gnomAD 1-116754644-A-G, CADD 1.56
- E26R (p.Glu26Arg), NCI-TCGA TCGA novel, MetaLR 0.16, MetaSVM -0.84, Variant assessed as somatic; high impact.
- I27T (p.Ile27Thr), Ensembl rs973062754, MetaLR 0.05, MetaSVM -1.07
- I27V (p.Ile27Val), gnomAD rs1272908324, REVEL 0.10, MetaLR 0.09
- T28A (p.Thr28Ala), NCI-TCGA TCGA novel, MetaLR 0.09, MetaSVM -0.93, Variant assessed as somatic; moderate impact.
- T28M (p.Thr28Met), rs369310866, ClinGen CA1027027, cosmic curated COSV65643, ClinVar RCV004227436, REVEL 0.21, MetaLR 0.10, Uncertain significance, not specified
- T28T (p.Thr28Thr), rs1196179366, gnomAD 1-116754653-G-A, CADD 0.45
- N29N (p.Asn29Asn), gnomAD 1-116754656-T-C, CADD 1.16
- A30G (p.Ala30Gly), TOPMed rs1275889182
- A30S (p.Ala30Ser), TOPMed rs952519710
- A30T (p.Ala30Thr), TOPMed rs952519710
- A30V (p.Ala30Val), TOPMed rs1275889182, MetaLR 0.12, MetaSVM -0.91
- A30A (p.Ala30Ala), gnomAD 1-116754659-C-T, CADD 0.98
- L31F (p.Leu31Phe), ExAC rs769370796, gnomAD rs769370796, REVEL 0.09, MetaLR 0.09
- E32K (p.Glu32Lys), NCI-TCGA Cosmic COSV6564, cosmic curated COSV65643, MetaLR 0.05, MetaSVM -1.05, Variant assessed as somatic; moderate impact.
- T33A (p.Thr33Ala), TOPMed rs1193958289, REVEL 0.07, MetaLR 0.04
- W34L (p.Trp34Leu), Ensembl rs2101152260, MetaLR 0.20, MetaSVM -0.97
- G35D (p.Gly35Asp), Ensembl rs267597946, MetaLR 0.31, MetaSVM -0.68
- G35V (p.Gly35Val), gnomAD 1-116754673-G-T, REVEL 0.43, MetaLR 0.25
- G35G (p.Gly35Gly), gnomAD 1-116754674-T-A, CADD 0.59
- A36T (p.Ala36Thr), NCI-TCGA Cosmic COSV1010, cosmic curated COSV10104, MetaLR 0.07, MetaSVM -1.03, Variant assessed as somatic; moderate impact.
- A36V (p.Ala36Val), gnomAD 1-116754676-C-T, REVEL 0.18, MetaLR 0.08
- A36D (p.Ala36Asp), gnomAD 1-116754676-C-A, REVEL 0.17, MetaLR 0.15
- L37S (p.Leu37Ser), ExAC rs775203706, gnomAD rs775203706, REVEL 0.28, MetaLR 0.29
- G38D (p.Gly38Asp), rs762609016, ClinGen CA1027030, ClinVar RCV004341710, ExAC rs762609016, REVEL 0.05, MetaLR 0.02, Likely benign, not specified
- G38R (p.Gly38Arg), gnomAD 1-116754681-G-C, REVEL 0.07, MetaLR 0.08
- I41L (p.Ile41Leu), rs763636317, ClinGen CA341839500, ClinVar RCV004322477, AlphaMissense 0.11, MetaLR 0.01, Uncertain significance, not specified
- I41T (p.Ile41Thr), TOPMed rs1478852347, gnomAD rs1478852347, REVEL 0.23, MetaLR 0.07
- I41V (p.Ile41Val), ExAC rs763636317, gnomAD rs763636317, REVEL 0.01, AlphaMissense 0.11
- N42S (p.Asn42Ser), ExAC rs773856061, TOPMed rs773856061, gnomAD rs773856061, REVEL 0.08, MetaLR 0.07
- N42N (p.Asn42Asn), rs189209558, gnomAD 1-116754695-C-T, CADD 1.73
- L43S (p.Leu43Ser), TOPMed rs994384732, MetaLR 0.12, MetaSVM -1.04
- D44N (p.Asp44Asn), gnomAD 1-116754699-G-A, REVEL 0.03, MetaLR 0.05
- D44D (p.Asp44Asp), rs766786239, gnomAD 1-116754701-C-T, CADD 2.50
- I45T (p.Ile45Thr), ExAC rs755341854, gnomAD rs755341854, REVEL 0.40, MetaLR 0.29
- I45V (p.Ile45Val), ExAC rs754207272, gnomAD rs754207272, REVEL 0.20, MetaLR 0.22
- P46A (p.Pro46Ala), cosmic curated COSV10104, 1000Genomes rs142374557, ESP rs142374557, ExAC rs142374557, REVEL 0.13, MetaLR 0.10
- P46L (p.Pro46Leu), ExAC rs752907362, gnomAD rs752907362, REVEL 0.14, MetaLR 0.25
- S47G (p.Ser47Gly), rs1447057669, ClinGen CA341839537, ClinVar RCV004433296, TOPMed rs1447057669, REVEL 0.07, MetaLR 0.02, Likely benign, not specified
- S47R (p.Ser47Arg), NCI-TCGA Cosmic COSV6564, cosmic curated COSV65643, Variant assessed as somatic; moderate impact.
- S47T (p.Ser47Thr), ExAC rs758486245, TOPMed rs758486245, gnomAD rs758486245, MetaLR 0.04, MetaSVM -1.02
- S47S (p.Ser47Ser), gnomAD 1-116754710-T-C, CADD 1.57
- F48C (p.Phe48Cys), gnomAD 1-116754712-T-G, REVEL 0.14, MetaLR 0.23
- Q49* (p.Gln49Ter), cosmic curated COSV10606, TOPMed rs1287434511, gnomAD rs1287434511, CADD 30.00
- Q49E (p.Gln49Glu), TOPMed rs1287434511, gnomAD rs1287434511, REVEL 0.14, MetaLR 0.10
- Q49R (p.Gln49Arg), rs2526243921, ClinGen CA341839554, ClinVar RCV004108315, Uncertain significance, not specified
- M50I (p.Met50Ile), NCI-TCGA Cosmic COSV6564, cosmic curated COSV65643, REVEL 0.08, MetaLR 0.09, Variant assessed as somatic; moderate impact.
- M50V (p.Met50Val), gnomAD 1-116754717-A-G, REVEL 0.10, MetaLR 0.06
- S51N (p.Ser51Asn), ExAC rs777764557, gnomAD rs777764557, REVEL 0.03, MetaLR 0.06
- S51R (p.Ser51Arg), ExAC rs746982566, gnomAD rs746982566, REVEL 0.17, MetaLR 0.13
- S51G (p.Ser51Gly), gnomAD 1-116754720-A-G, REVEL 0.05, MetaLR 0.08
- S51S (p.Ser51Ser), rs746982566, gnomAD 1-116754722-T-C, CADD 1.16
- D52G (p.Asp52Gly), gnomAD rs1337997291, REVEL 0.10, MetaLR 0.05
- D52N (p.Asp52Asn), gnomAD 1-116754723-G-A, REVEL 0.05, MetaLR 0.07
- D52D (p.Asp52Asp), rs916355942, gnomAD 1-116754725-T-C, CADD 0.13
- D52E (p.Asp52Glu), gnomAD 1-116754725-T-A, REVEL 0.06, MetaLR 0.04
- D53N (p.Asp53Asn), gnomAD rs1259308633, REVEL 0.00, MetaLR 0.01
- D53G (p.Asp53Gly), gnomAD 1-116754727-A-G, REVEL 0.01, MetaLR 0.01
- D53D (p.Asp53Asp), rs888647868, gnomAD 1-116754728-T-C, CADD 0.29
- I54V (p.Ile54Val), ExAC rs757140428, gnomAD rs757140428, REVEL 0.02, MetaLR 0.05, Uncertain significance, not specified
- I54T (p.Ile54Thr), gnomAD 1-116754730-T-C, REVEL 0.04, MetaLR 0.12
- D55E (p.Asp55Glu), ESP rs143289040, ExAC rs143289040, TOPMed rs143289040, gnomAD rs143289040, REVEL 0.02, MetaLR 0.01, Uncertain significance, not specified
- D55G (p.Asp55Gly), gnomAD rs1212533570, REVEL 0.03, MetaLR 0.05
- D55N (p.Asp55Asn), gnomAD 1-116754732-G-A, REVEL 0.01, MetaLR 0.03
- D55D (p.Asp55Asp), rs143289040, gnomAD 1-116754734-C-T, CADD 0.04
- D56N (p.Asp56Asn), rs1024165793, NCI-TCGA Cosmic COSV6564, cosmic curated COSV65643, TOPMed rs1024165793, REVEL 0.13, MetaLR 0.24, Variant assessed as somatic; moderate impact.
- D56V (p.Asp56Val), TOPMed rs1370035078, REVEL 0.24, MetaLR 0.27
- D56H (p.Asp56His), gnomAD 1-116754735-G-C, REVEL 0.16, MetaLR 0.14
- D56D (p.Asp56Asp), rs372593281, gnomAD 1-116754737-T-C, CADD 0.34
- I57V (p.Ile57Val), ExAC rs769613740, TOPMed rs769613740, gnomAD rs769613740, REVEL 0.14, MetaLR 0.08
- I57T (p.Ile57Thr), gnomAD 1-116754739-T-C, REVEL 0.26, MetaLR 0.24
- I57K (p.Ile57Lys), gnomAD 1-116754739-T-A, REVEL 0.37, MetaLR 0.24
- I57I (p.Ile57Ile), rs1476730348, gnomAD 1-116754740-A-C, CADD 0.40
- K58K (p.Lys58Lys), rs1172651131, gnomAD 1-116754743-A-G, CADD 1.22
- W59R (p.Trp59Arg), gnomAD 1-116754744-T-C, REVEL 0.68, MetaLR 0.61
- E60G (p.Glu60Gly), ExAC rs779582184, gnomAD rs779582184, REVEL 0.15, MetaLR 0.13
- T62L (p.Thr62Leu), rs750577393, gnomAD 1-116754747-GA-G, CADD 15.10
- T62S (p.Thr62Ser), gnomAD 1-116754753-A-T, REVEL 0.01, MetaLR 0.00
- T62I (p.Thr62Ile), gnomAD 1-116754754-C-T, REVEL 0.00, MetaLR 0.01
- T62T (p.Thr62Thr), rs1324046303, gnomAD 1-116754755-T-C, CADD 2.45
- D64N (p.Asp64Asn), ExAC rs748882704, gnomAD rs748882704, REVEL 0.03, MetaLR 0.04
- K65* (p.Lys65Ter), gnomAD 1-116754762-A-T, CADD 25.80
- K66T (p.Lys66Thr), ExAC rs768312834, gnomAD rs768312834, REVEL 0.04, MetaLR 0.00
- K66E (p.Lys66Glu), gnomAD 1-116754765-A-G, REVEL 0.05, MetaLR 0.02
- K66R (p.Lys66Arg), gnomAD 1-116754766-A-G, REVEL 0.08, MetaLR 0.01
- K67N (p.Lys67Asn), NCI-TCGA TCGA novel, REVEL 0.17, MetaLR 0.23, Variant assessed as somatic; moderate impact.
- K67R (p.Lys67Arg), gnomAD 1-116754764-GA-G, CADD 20.70
- K67* (p.Lys67Ter), gnomAD 1-116754768-A-T, CADD 33.00
- I68V (p.Ile68Val), gnomAD 1-116754771-A-G, REVEL 0.02, MetaLR 0.05
- I68T (p.Ile68Thr), gnomAD 1-116754772-T-C, REVEL 0.13, MetaLR 0.27
- I68I (p.Ile68Ile), gnomAD 1-116754773-T-C, CADD 2.19
- A69T (p.Ala69Thr), NCI-TCGA Cosmic COSV6564, cosmic curated COSV65643, REVEL 0.09, MetaLR 0.25, Variant assessed as somatic; moderate impact.
- Q70* (p.Gln70Ter), gnomAD 1-116754777-C-T, CADD 32.00
- F71L (p.Phe71Leu), gnomAD 1-116754780-T-C, REVEL 0.02, MetaLR 0.07
- K73R (p.Lys73Arg), TOPMed rs1651783803, REVEL 0.04, MetaLR 0.04
- E74K (p.Glu74Lys), gnomAD 1-116754789-G-A, REVEL 0.01, MetaLR 0.00
- E74D (p.Glu74Asp), gnomAD 1-116754791-G-T, REVEL 0.02, MetaLR 0.00
- K75I (p.Lys75Ile), NCI-TCGA Cosmic COSV1010, cosmic curated COSV10104, MetaLR 0.09, MetaSVM -0.93, Variant assessed as somatic; moderate impact.
- K75E (p.Lys75Glu), gnomAD 1-116754792-A-G, REVEL 0.14, MetaLR 0.11
- K75K (p.Lys75Lys), rs752991154, gnomAD 1-116754794-A-G, CADD 1.08
- E76D (p.Glu76Asp), cosmic curated COSV65643, Ensembl rs1361232183, REVEL 0.14, MetaLR 0.03
- E76Q (p.Glu76Gln), ExAC rs761382880, gnomAD rs761382880, REVEL 0.09, MetaLR 0.04
- E76V (p.Glu76Val), gnomAD rs1651784362, REVEL 0.17, MetaLR 0.03
- E76K (p.Glu76Lys), gnomAD 1-116754795-G-A, REVEL 0.08, MetaLR 0.03
- E76E (p.Glu76Glu), gnomAD 1-116754797-G-A, CADD 0.05
- T77S (p.Thr77Ser), ExAC rs771384035, gnomAD rs771384035, REVEL 0.07, MetaLR 0.06
- T77I (p.Thr77Ile), gnomAD 1-116754799-C-T, REVEL 0.14, MetaLR 0.07
- F78C (p.Phe78Cys), NCI-TCGA TCGA novel, MetaLR 0.15, MetaSVM -0.51, Variant assessed as somatic; moderate impact.
- F78L (p.Phe78Leu), gnomAD rs1334824140, REVEL 0.17, MetaLR 0.06
- F78S (p.Phe78Ser), gnomAD rs1232141904, REVEL 0.22, MetaLR 0.07
- F78F (p.Phe78Phe), rs777192186, gnomAD 1-116754803-C-T, CADD 0.60
- E80G (p.Glu80Gly), rs2526244194, ClinGen CA341839783, ClinVar RCV004365823, REVEL 0.19, MetaLR 0.06, Uncertain significance, not specified
- E80K (p.Glu80Lys), NCI-TCGA Cosmic COSV6564, cosmic curated COSV65643, REVEL 0.07, MetaLR 0.04, Variant assessed as somatic; moderate impact.
- E80Q (p.Glu80Gln), gnomAD 1-116754807-G-C, REVEL 0.08, MetaLR 0.06
- K81K (p.Lys81Lys), gnomAD 1-116754812-A-G, CADD 0.22
- D82E (p.Asp82Glu), Ensembl rs928156501, REVEL 0.09, MetaLR 0.03
- D82N (p.Asp82Asn), Ensembl rs749760513, REVEL 0.08, MetaLR 0.09
- D82I (p.Asp82Ile), gnomAD 1-116754807-GA-G, CADD 0.03
- D82D (p.Asp82Asp), gnomAD 1-116754815-T-C, CADD 0.94
- T83I (p.Thr83Ile), ExAC rs759876441, TOPMed rs759876441, gnomAD rs759876441, REVEL 0.14, MetaLR 0.16, Uncertain significance, not specified
- T83K (p.Thr83Lys), NCI-TCGA Cosmic COSV6564, cosmic curated COSV65643, MetaLR 0.04, MetaSVM -1.00, Variant assessed as somatic; moderate impact.
- Y84* (p.Tyr84Ter), NCI-TCGA Cosmic COSV1010, cosmic curated COSV10104, Variant assessed as somatic; high impact.
- Y84H (p.Tyr84His), rs1358000886, NCI-TCGA Cosmic COSV6564, cosmic curated COSV65643, gnomAD rs1358000886, REVEL 0.18, MetaLR 0.08, Variant assessed as somatic; moderate impact.
- Y84Y (p.Tyr84Tyr), rs765584225, gnomAD 1-116754821-T-C, CADD 0.07
- K85E (p.Lys85Glu), TOPMed rs970858006, gnomAD rs970858006, REVEL 0.02, MetaLR 0.02, Likely benign, not specified
- K85N (p.Lys85Asn), NCI-TCGA TCGA novel, MetaLR 0.04, MetaSVM -1.11, Variant assessed as somatic; moderate impact.
- K85R (p.Lys85Arg), 1000Genomes rs181664416, ExAC rs181664416, TOPMed rs181664416, gnomAD rs181664416, REVEL 0.10, MetaLR 0.08
- K85K (p.Lys85Lys), rs763125349, gnomAD 1-116754824-G-A, CADD 0.30
- L86L (p.Leu86Leu), gnomAD 1-116754825-C-T, CADD 0.05
- F87Y (p.Phe87Tyr), ExAC rs764184117, gnomAD rs764184117, REVEL 0.10, MetaLR 0.06
Public CD2 analysis runs
- CD2 analysis run — CD2 (685 variants) — completed 2026-08-20